Daniel Marsh

Daniel Marsh

Senior Markets Analyst

Daniel Marsh is a senior markets analyst at StockTi with over 12 years of experience covering U.S. and global equity markets. He holds a CFA charter and previously worked as an equity research associate at a major Wall Street firm. Daniel specializes in macroeconomic analysis, market trends, and cross-sector investment themes. His work focuses on translating complex market data into actionable insights for individual and institutional investors.

Markets, Economy, Analysis 1,517 articles

Articles by Daniel Marsh

Nu Holdings Shares Dip Amid U.S. Expansion Push, Investor Cost Concerns
Markets

Nu Holdings Shares Dip Amid U.S. Expansion Push, Investor Cost Concerns

Nu Holdings shares declined in early trading as the digital bank announced new executive hires and partnerships to fuel its U.S. expansion. Investors are weighing robust growth against increasing spending and credit provisions.

NU
American Airlines Shares Pressured as Oil Surge Squeezes Margins
Markets

American Airlines Shares Pressured as Oil Surge Squeezes Margins

American Airlines shares fell as oil prices surged past $100 per barrel, significantly increasing jet fuel expenses. The carrier faces greater exposure than competitors due to its lack of fuel hedging.

AAL DAL UAL LUV USO
Hims & Hers Stock Extends Rally on Novo Nordisk Patent Settlement
Markets

Hims & Hers Stock Extends Rally on Novo Nordisk Patent Settlement

Shares of Hims & Hers Health continued their ascent following a resolution to a patent conflict with Novo Nordisk, which will reintroduce branded GLP-1 medications to its service. Analysts have upgraded the stock but caution about potential margin pressures.

HIMS NVO LLY
Indian Equities Under Pressure as Oil Surge, Rupee Weakness Stoke Macro Fears
Markets

Indian Equities Under Pressure as Oil Surge, Rupee Weakness Stoke Macro Fears

Indian benchmarks extended losses Thursday, pressured by oil prices exceeding $100 a barrel and a record-low rupee. Analysts warn of a widening current account deficit and slower GDP growth.

HDB IBN
ASX 200 Plunges on Oil Spike, RBA Rate Hike Bets Surge
Markets

ASX 200 Plunges on Oil Spike, RBA Rate Hike Bets Surge

The S&P/ASX 200 dropped 1.3% to 8,629.00 as surging oil prices above $100 a barrel fueled expectations of another Reserve Bank rate hike. Market pricing now implies a 75% probability of an increase next week.

CBAUF ASX USO XLE XLF
FTSE 100 Retreats on Oil Spike, Rate Cut Hopes Dim
Markets

FTSE 100 Retreats on Oil Spike, Rate Cut Hopes Dim

London's FTSE 100 declined 0.7% in early Thursday trading as Brent crude surged past $100 a barrel, dampening expectations for near-term Bank of England rate cuts and pressuring consumer-focused sectors.

BP SHEL LVMUY AZN NVS HSBC RHHBY TM BABA SAP SIEGY SSNLF BACHY USO XLE XLF
Global Markets React to Geopolitical Tensions and Sector Data
Markets

Global Markets React to Geopolitical Tensions and Sector Data

Indian equities tumbled as oil surged past $100 amid Middle East tensions, while Singapore's SGX reported a six-year high in trading activity. Commodity markets saw soybean gains on strong export data.

HSBC FXI USO GLD SLV UNG XLF XLE XLV
Dow Drops 418 Points as Oil Supply Fears Eclipse Tame CPI Data
Markets

Dow Drops 418 Points as Oil Supply Fears Eclipse Tame CPI Data

The Dow Jones Industrial Average declined 418 points Wednesday as investor focus shifted from benign inflation data to escalating oil supply risks stemming from Middle East conflict. Oracle stock jumped sharply on an upbeat revenue forecast.

ORCL USO XLE
Bank of America Shares Dip Amid Mixed Q1 Signals and Market Jitters
Markets

Bank of America Shares Dip Amid Mixed Q1 Signals and Market Jitters

Bank of America shares declined 1.5% to $47.86, erasing prior gains, even as co-president Dean Athanasia projected strong first-quarter growth in net interest income and investment banking fees. The drop mirrored a broader sell-off in financial stocks amid persistent inflation worries.

BAC C JPM WFC GS XLF USO
Pfizer Shares Dip Amid Vaccine Policy Clarity, Eczema Drug Progress
Analysis

Pfizer Shares Dip Amid Vaccine Policy Clarity, Eczema Drug Progress

Pfizer shares declined slightly as regulatory scrutiny of mRNA vaccines eased, offset by positive mid-stage trial results for its experimental eczema drug tilrekimig.

PFE REGN SNY LLY NVO
Opendoor Gains on Housing Data, Mortgage Beta Draws Investor Scrutiny
Markets

Opendoor Gains on Housing Data, Mortgage Beta Draws Investor Scrutiny

Opendoor Technologies shares advanced as its weekly home acquisition contracts rose 12%. The company's new 4.99% 30-year mortgage offer, currently in beta testing, is drawing investor attention amid broader housing market resilience.

OPEN RKT Z
BAE Systems Shares Dip Amid European Defense Sector Sell-Off
Markets

BAE Systems Shares Dip Amid European Defense Sector Sell-Off

BAE Systems' stock declined alongside a broader drop in European defense shares after Rheinmetall's sales forecast disappointed. The company reported a record order backlog and continues its share repurchase program.

BAESY RHHBY LMT RTX XLE USO